Overview

A Phase 2 Study of the Latanoprost Punctal Plug Delivery System in Subjects With Ocular Hypertension or Open-Angle Glaucoma

Status:
Withdrawn
Trial end date:
2009-07-01
Target enrollment:
0
Participant gender:
All
Summary
The purpose of this study is to evaluate IOP response to experimental dose of Latanoprost- PPDS in subjects with ocular hypertension or open-angle glaucoma.
Phase:
Phase 2
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Mati Therapeutics Inc.
Treatments:
Latanoprost
Criteria
Inclusion Criteria:

- Over 18 yrs of age with ocular hypertension or open-angle glaucoma

- Subjects who have a best corrected visual acuity of 20/100 or better

Exclusion Criteria:

- Subjects who wear contact lenses.

- Uncontrolled medical conditions

- Subjects requiring chronic topical artifical tears, lubricants and/or requiring any
other chronic topical medications

- Subjects who have a history of chronic or recurrent inflammatory eye disease